Literature DB >> 11757641

Pulmonary toxicity with mefloquine.

E Udry1, F Bailly, M Dusmet, P Schnyder, R Lemoine, J W Fitting.   

Abstract

This report presents a case of acute lung injury developing within hours after administration of mefloquine for a low-level Plasmodium falciparum malaria, which was persistent despite halofantrine therapy. Extensive microbiological investigation remained negative and video-assisted thoracoscopic lung biopsy demonstrated diffuse alveolar damage. The evolution was favourable without treatment. This is the second report of acute lung injury and diffuse alveolar damage caused by mefloquine. Glucose-6-phosphate dehydrogenase deficiency was present in the former case and was thought to contribute to the lung injury. However, glucose-phosphate dehydrogenase was normal in the present case, suggesting that it is not a predisposing condition to the lung injury.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11757641     DOI: 10.1183/09031936.01.00208001

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  1 in total

1.  The anti-malarial drug Mefloquine disrupts central autonomic and respiratory control in the working heart brainstem preparation of the rat.

Authors:  Varinder K Lall; Mathias Dutschmann; Jim Deuchars; Susan A Deuchars
Journal:  J Biomed Sci       Date:  2012-12-15       Impact factor: 8.410

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.